Long-term systemic administration of unconjugated morpholino oligomers for therapeutic expression of dystrophin by exon skipping in skeletal muscle: implications for cardiac muscle integrity

Go down

Back to top


 
Permissions in this forum:
You cannot reply to topics in this forum